Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Prolonged Exposure Therapy for PTSD
NCT03960658Phase 2Completed
- Start
- Apr 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in post-traumatic stress disorder (PTSD). Started Apr 2019; status: completed.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03960658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960658.